| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3269729 | HPB | 2011 | 8 Pages |
Abstract
The liver-first approach is feasible in approximately four-fifths of patients and can be performed with peri-operative mortality and morbidity similar to the traditional treatment paradigm. Patients treated with this novel strategy derive a considerable overall-survival-benefit, although disease-recurrence-rates remain relatively high, necessitating a multidisciplinary approach.
Related Topics
Health Sciences
Medicine and Dentistry
Endocrinology, Diabetes and Metabolism
Authors
Mechteld C. de Jong, Ronald M. van Dam, Monique Maas, Marc H.A. Bemelmans, Steven W.M. Olde Damink, Geerard L. Beets, Cornelis H.C. Dejong,